These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 4215343)

  • 1. Replacement of lysine by arginine, phenylalanine, and tryptophan in the reactive site of the trypsin-kallikrein inhibitor (Kunitz).
    Jering H; Tschesche H
    Angew Chem Int Ed Engl; 1974 Oct; 13(10):662-3. PubMed ID: 4215343
    [No Abstract]   [Full Text] [Related]  

  • 2. Replacement of lysine by arginine, phenylalanine and tryptophan in the reactive site of the bovine trypsin-kallikrein inhibitor (Kunitz) and change of the inhibitory properties.
    Jering H; Tschesche H
    Eur J Biochem; 1976 Jan; 61(2):453-63. PubMed ID: 129327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of the trypsin-kallikrein inhibitor (Kunitz) by cleavage of the dipeptide Ala 16--Arg 17 in the reactive site.
    Jering H; Tschesche H
    Angew Chem Int Ed Engl; 1974 Oct; 13(10):663. PubMed ID: 4215344
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of the active derivative of bovine trypsin-kallikrein inhibitor (Kunitz) with open peptide bond in the reactive site.
    Jering H; Tschesche H
    Angew Chem Int Ed Engl; 1974 Oct; 13(10):660-1. PubMed ID: 4215341
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preparation and properties of active derivatives of the trypsin-kallikrein inhibitor from bovine organs].
    Fritz H; Schult H; Meister R; Werle E
    Hoppe Seylers Z Physiol Chem; 1969 Dec; 350(12):1531-40. PubMed ID: 4243596
    [No Abstract]   [Full Text] [Related]  

  • 6. Identity of the tryptic and alpha-chymotryptic reactive sites on soybean trypsin inhibitor (Kunitz).
    De Vonis Bidlingmeyer U; Leary TR; Laskowski M
    Biochemistry; 1972 Aug; 11(17):3303-10. PubMed ID: 5065479
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzymatic replacement of the arginyl by a lysyl residue in the reactive site of soybean trypsin inhibitor.
    Sealock RW; Laskowski M
    Biochemistry; 1969 Sep; 8(9):3703-10. PubMed ID: 5387527
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigations of the complement-fixing sites of immunoglobulins.
    Johnson BJ; Thames KE
    J Immunol; 1976 Nov; 117(5 Pt 1):1491-4. PubMed ID: 1002987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinase catalyzed resynthesis of the peptide bond Lys 15--Ala 16 in the derivative of trypsin-kallikrein inhibitor (Kunitz) with this peptide bond hydrolyzed.
    Jering H; Tschesche H
    Angew Chem Int Ed Engl; 1974 Oct; 13(10):661-2. PubMed ID: 4215342
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the kinetics of the reaction between kallikrein inactivator and trypsin].
    Pütter J
    Hoppe Seylers Z Physiol Chem; 1967 Sep; 348(9):1197-206. PubMed ID: 5301336
    [No Abstract]   [Full Text] [Related]  

  • 11. [Basic pancreatic trypsin inhibitor].
    Terada S; Izumiya N
    Tanpakushitsu Kakusan Koso; 1972 Apr; 17(4):283-93. PubMed ID: 4559219
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemical modification and catalytic activity of carbonate-hydro-lyase B from bovine erythrocytes. Modification of arginine, histidine, lysine, tyrosine and tryptophan].
    Nees S; Schmidt W; Schneider F
    Hoppe Seylers Z Physiol Chem; 1971 Mar; 352(3):355-68. PubMed ID: 4994525
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthetic peptides and fluorogenic substrates related to the reactive site sequence of Kunitz-type inhibitors isolated from Bauhinia: interaction with human plasma kallikrein.
    Oliva ML; Santomauro-Vaz EM; Andrade SA; Juliano MA; Pott VJ; Sampaio MU; Sampaio CA
    Biol Chem; 2001 Jan; 382(1):109-13. PubMed ID: 11258660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Constitution of frog hemoglobins (Rana ridibunda)].
    Christomanos AA
    Enzymologia; 1967 May; 32(4):301-19. PubMed ID: 5621954
    [No Abstract]   [Full Text] [Related]  

  • 15. The X-ray structures of porcine pancreatic kallikrein and of its complex with bovine pancreatic trypsin inhibitor.
    Bode W; Chen Z
    Adv Exp Med Biol; 1983; 156():289-308. PubMed ID: 6190368
    [No Abstract]   [Full Text] [Related]  

  • 16. Stopped-flow kinetics of the resynthesis of the reactive site peptile bond in kallikrein inhibitor (Kunitz) by beta-trypsin.
    Quast U; Engel J; Steffen E; Tschesche H; Kupfer S
    Biochemistry; 1978 May; 17(9):1675-82. PubMed ID: 26384
    [No Abstract]   [Full Text] [Related]  

  • 17. High-resolution structures of three new trypsin-squash-inhibitor complexes: a detailed comparison with other trypsins and their complexes.
    Helland R; Berglund GI; Otlewski J; Apostoluk W; Andersen OA; Willassen NP; Smalås AO
    Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):139-48. PubMed ID: 10089404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spatial orientation of the essential amino acid residues arginine and aspartate within the alpha1beta1 integrin recognition site of collagen IV has been resolved using fluorescence resonance energy transfer.
    Golbik R; Eble JA; Ries A; Kühn K
    J Mol Biol; 2000 Mar; 297(2):501-9. PubMed ID: 10715216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical approaches to the properties of active sites of enzymes.
    Vallee BL; Riordan JF
    Annu Rev Biochem; 1969; 38():733-94. PubMed ID: 4896248
    [No Abstract]   [Full Text] [Related]  

  • 20. Properties of a human seminal plasma inhibitor for trypsin.
    Hirschhäuser C; Kionke M
    Fertil Steril; 1971 Jun; 22(6):360-6. PubMed ID: 4253474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.